A 52-year-old woman with a 10-year history of rheumatoid arthritis presents with nephrotic syndrome (proteinuria 4.5 g/day, serum albumin 2.1 g/dL). Renal ultrasound shows normal-sized kidneys without obstruction. Which investigation is most appropriate to confirm the diagnosis of secondary amyloidosis?

Question

Accepted Answer

B. Renal biopsy with Congo red staining and mass spectrometry for amyloid typing. ## Diagnosis of Secondary (AA) Amyloidosis in Rheumatoid Arthritis

**Key Point:** Renal biopsy with Congo red staining and mass spectrometry is the gold standard for confirming secondary amyloidosis (AA amyloidosis) in the setting of chronic inflammatory disease.

### Clinical Context: Secondary Amyloidosis in RA

Secondary amyloidosis (AA type) occurs in chronic inflammatory conditions:
- Rheumatoid arthritis (most common systemic autoimmune cause)
- Chronic infections (tuberculosis, osteomyelitis)
- Chronic inflammatory bowel disease
- Malignancy (Hodgkin lymphoma, renal cell carcinoma)

In this case, 10 years of RA with nephrotic syndrome strongly suggests AA amyloidosis.

### Why Renal Biopsy with Congo Red Staining?

| Feature | Significance |
|---------|-------------|
| **Congo red staining** | Binds amyloid fibrils; produces apple-green birefringence under polarized light |
| **Polarized light microscopy** | Confirms amyloid deposition; pathognomonic finding |
| **Mass spectrometry** | Identifies amyloid type (AA vs. AL vs. ATTR); critical for prognosis and treatment |
| **Electron microscopy** | Visualizes characteristic 7–10 nm unbranched fibrils |

**High-Yield:** In secondary amyloidosis, mass spectrometry is essential because:
- Confirms **AA amyloidosis** (derived from serum amyloid A, an acute-phase reactant)
- Distinguishes from AL amyloidosis (which would require different treatment)
- Guides management: AA amyloidosis requires control of underlying inflammation; AL requires chemotherapy

### Diagnostic Algorithm for Nephrotic Syndrome with Chronic RA

```mermaid
flowchart TD
  A[RA + Nephrotic syndrome]:::outcome --> B[Renal ultrasound]:::action
  B --> C{Normal kidneys?}:::decision
  C -->|Yes| D[Exclude obstruction/diabetic nephropathy]:::outcome
  D --> E[Renal biopsy indicated]:::action
  E --> F[Congo red staining]:::action
  F --> G{Apple-green birefringence?}:::decision
  G -->|Yes| H[Amyloidosis confirmed]:::outcome
  H --> I[Mass spectrometry for typing]:::action
  I --> J{AA or AL?}:::decision
  J -->|AA| K[Control inflammation: NSAIDs, biologics]:::action
  J -->|AL| L[Chemotherapy + stem cell transplant]:::action
```

**Clinical Pearl:** Nephrotic syndrome in a patient with long-standing RA should raise suspicion for amyloidosis. Unlike diabetic nephropathy (which shows nodular glomerulosclerosis), amyloidosis shows characteristic amyloid deposits on Congo red staining.

**Mnemonic: AA amyloidosis risk factors — CHIT**
- **C**hronic inflammation (RA, IBD)
- **H**ealth conditions (TB, osteomyelitis)
- **I**nflammatory bowel disease
- **T**umors (Hodgkin, RCC)

[cite:Robbins 10e Ch 6]

Answer

A. 24-hour urine protein estimation and serum creatinine measurement

Answer

C. Serum protein electrophoresis and immunofixation electrophoresis

Answer

D. Renal ultrasound with Doppler assessment of renal blood flow

Explanation

Diagnosis of Secondary (AA) Amyloidosis in Rheumatoid Arthritis

Clinical Context: Secondary Amyloidosis in RA

Why Renal Biopsy with Congo Red Staining?

Diagnostic Algorithm for Nephrotic Syndrome with Chronic RA

Practice similar questions

Join our NEET PG community

Feature	Significance
Congo red staining	Binds amyloid fibrils; produces apple-green birefringence under polarized light
Polarized light microscopy	Confirms amyloid deposition; pathognomonic finding
Mass spectrometry	Identifies amyloid type (AA vs. AL vs. ATTR); critical for prognosis and treatment
Electron microscopy	Visualizes characteristic 7–10 nm unbranched fibrils